Iberdomide may boost chimeric antigen receptor (CAR) T-cell expansion and functionality in patients with multiple myeloma, announced researchers at Mount Sinai and Bristol Myers Squibb today.1 Their observations are part of a phase 1b/2a clinical tri... [3340 chars].. reed more
